51
|
Dupitout L, Ferrière J, Bernhard J, Bensadoun H, Bladou F, Capon G, Estrade V, Robert G. Urolift sous anesthésie locale : expérience préliminaire. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
52
|
Debard C, Bernhard J, Michiels C, Nam-son V, Le Quellec A, Blanc P, Capon G, Robert G, Bensadoun H, Ferrière J, Bladou F. Néphrectomie partielle de rattrapage robot-assistée après échec de cryothérapie. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
53
|
Clement K, Alezra E, Marquette T, Capon G, Bensadoun H, Ferriere J, Jean-Christophe B, Bladou F, Robert G. Évolution de la prise en charge des énucléations laser holmium (HoLEP) en ambulatoire : impact du volume opératoire et de la courbe d’apprentissage. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
54
|
Gury L, Mallet R, Robert G. Technique d’énucléation prostatique en « monobloc » au laser Holmium : évaluation bicentrique à propos de 109 cas. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
55
|
Hutin M, Thezenas S, Timsit M, Pettenati C, Gallon J, Karam G, Branchereau J, Heldhli O, Badet L, Matillon X, Salomon L, Cholley I, Bessede T, Neuzillet Y, Robert G, Bensadoun H, Allenet C, Cormier L, Schneider A, Leclercq V, Sallusto F, Descazeaud A, Peyronnet B, Hascoet J, Bouye S, Lechevallier E, Delaporte V, Lannes F, Boutin J, Berthelot L, Iborra F, Thuret R. Incidence et morbi-mortalité des tumeurs de la voie excrétrice du transplant après transplantation rénale : étude multicentrique française. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
56
|
Clement K, Debard C, Mosillo L, Bladou F, Capon G, Robert G, Bensadoun H, Ferriere J, Bernhard J. Technique d’énucléation robot-assistée d’une tumeur rénale endophytique endosinusale. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
57
|
Cereda B, Allenet C, Covin B, Beauval J, Robert G, Abdo N, Cabaniols L, Robert M, Thuret R, Murez T. Prise en charge des traumatismes de l’urètre postérieur dans les fractures du bassin chez l’homme : comparaison du réalignement endoscopique précoce versus urétroplastie différée. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.070] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
58
|
Peyronnet B, Belas O, Capon G, Callerot P, Hascoet J, Manunta A, Descazeaud A, Robert G, Fournier G. Implantation robot-assistée du sphincter artificiel urinaire chez la femme : résultats à 3 ans de la voie antérieure. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
59
|
De Hauteclocque A, Michiels C, Sarrazin J, Faessel M, Mosillo L, Percot M, Blanc P, Bensadoun H, Bladou F, Robert G, Capon G, Estrade V, Ferrière J, Bos F, Bernhard J. La modélisation 3D, un support efficace de l’information-patient avant chirurgie rénale. (Étude UroCCR-39 : Rein-3D-Print). Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
60
|
Robert P, Leclercq F, Lattuca B, Albat B, Maupas E, Robert G, Akodad M, Macia JC, Dubar A, Targosz F, Gandet T, Cayla G. P1843Transcatheter aortic valve implantation in patients with uninterrupted vitamin k antagonist. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Bridging of vitamin K antagonist (VKA) with heparin is usually not promoted during interventional or surgical procedures related to increased risk of bleeding and thrombotic events but this strategy has not been evaluated during TAVI.
Purpose
The aim of this study was to evaluate the rate of major bleeding and vascular complications after TAVI performed in patients with uninterrupted VKA.
Methods
From January 2016 to October 2017, consecutive patients who underwent TAVI with uninterrupted VKA (INR between 1.5 and 3.5) were prospectively included in a monocentric registry. TAVI were performed according to current guidelines and a 50UI/kg bolus of heparin was injected at the beginning of the procedure for all patients. Vascular and bleeding complications were assessed using the Valve Academic Research Consortium 2 (VARC2) and the Bleeding Academic Research Consortium (BARC) definitions at 30 day follow-up.
Results
A total of 88 patients were included with a median age of 84 years [81.8–87], 42% being female, the median STS score was 5.1 [4.1–7.5], the median CHADS2-VASc was 5.5 [5–6] and 60.2% had a chronic kidney failure. Median INR at time of implantation was at 2.1 [1.8–2.6]. VKA were used for atrial fibrillation (89.8%), mechanic mitral prosthesis (5.7%) or venous thromboembolic disease (4.5%). Trans femoral access was used in 88.6% of the patients. Major bleeding (BARC ≥3b) occurred in 5 patients (5,7%) and major vascular complications occurred in 7 patients (8%). Peripheral arterial disease (RR = 10.95; 95% CI: 1.63 to 73.75; p=0.014) and carotid access (RR=8.56; 95% CI: 1.19 to 61.51; p=0.033) were significantly associated with major bleeding. INR >2.5 was significantly associated with vascular complications (RR=7.14; 95% CI: 1.29 to 39.63; p=0.025). In multivariate analysis, Body mass index (OR=1.26; 95% CI: 1.02 to 1.57; p=0.032) and INR >2.5 (OR=18.91; 95% CI: 1.62 to 221.26; p=0.010) were independent factor significantly associated with vascular complications or major bleeding. Mortality rate at 30 days follow-up was 2.3%, there was no myocardial infarction and stroke rate was 4.5%.
Figure 1. Study flowchart
Conclusion
TAVI with uninterrupted VKA treatment seems to be feasible and safe with low risk of bleeding and vascular complications in this first single centre experience. Particular caution is advocated in low BMI patients and to keep INR<2.5.
Collapse
|
61
|
Dupras R, Mills L, Robert G, Meunier C, Chorfi Y. 91 Can propylene glycol modulate insulin and insulin-like growth factor-1 in superovulated dairy heifers? Reprod Fertil Dev 2019. [DOI: 10.1071/rdv31n1ab91] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The aim of this study was to determine the effect of propylene glycol (PPG) on serum concentrations of insulin and insulin-like growth factor (IGF)-1 in superovulated dairy heifers. We hypothesised that administration of PPG would have a positive effect on superovulation results via increased insulin and IGF-1. A total of 20 clinically healthy Holstein heifers with an average age of 12 months were used for this experiment. Superovulation was performed using a standard protocol. Briefly, each heifer received 3mg of oestradiol-17β IM and an intravaginal progesterone-releasing insert (CIDR) containing 1.9g of progesterone at random stages of the oestrous cycle (designated Day 0). From Day 4 to 8, heifers received a total of 200mg of NIH-follicle-stimulating hormone-P1 administered intramuscularly through 9 injections of decreasing doses (from 50 to 10mg) at 12-h intervals. On Day 7, heifers received 2 injections of 500µg of cloprostenol, a PGF2α analogue, at ~6-h intervals, after which intravaginal inserts were removed. Artificial insemination was performed on Day 10, 12h after treatment with 100µg of gonadotropin-releasing hormone IM. Embryos were flushed from the uterus of donor heifers 6 days after AI. The method consisted of simultaneously using 1 catheter per uterine horn. Catheters were maintained in place to perform 2 flushes 1h apart. A total of 1L of flushing medium was used, 700 and 300mL for the first and the second flush, respectively. Embryos were assessed for viability immediately after collection using the IETS classification. Heifers were divided into 2 groups (PPG and control group). From Day 4 to 14 of the superovulation protocol, PPG group received a daily dose of 400mL of a 66.7% propylene glycol solution, whereas the control group received the same amount of water. Two months later, the same experiment was conducted by inverting the groups. At Day 4 and 14, four blood samples were collected to measure insulin and IGF-1 at 25-min intervals. The first sample (0) was taken before heifers received PPG or water. Insulin was analysed using an ELISA kit following manufacturer’s instructions, whereas IGF-1 was determined using a chemiluminescence immunoassay. Embryo associated data were analysed using t-test. Both IGF-1 and insulin data were analysed using a two-way ANOVA, followed by Bonferroni post-hoc test. Treatment with PPG had no effect on the number of transferable embryos (8±5.1v. 7±5.5), degenerated embryos (0.5±0.8v. 1.5±2.4), or unfertilized oocytes (0.3±0.7v. 0.7±1.2) recovered. There was also no effect of PPG on IGF-1 serum concentrations at the beginning (Day 4) or the end (Day 14) of the treatment regimen. However, PPG treatment enhanced (P = 0.02) serum insulin concentrations 50min after administration on Day 4 (10.69 v. 6.88 pmol/L), as well as at 25 (19.58 v. 9.64 pmol/L) and 50min (16.67v. 8.21 pmol/L) on Day 14. It has been suggested that PPG metabolism may stimulate insulin and IGF-1 secretion, which can promote embryo development. However, in the present study, there was no effect of oral doses of PPG on IGF-1. Although higher serum concentrations of insulin were observed after PPG treatment, there was no effect of PPG treatment on the number of transferable embryos recovered following superovulation.
Collapse
|
62
|
Gury L, Robert G, Bensadoun H. État des lieux de la chirurgie ambulatoire de l’obstruction sous-vésicale : l’effet laser ? Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.225] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
63
|
Michiels C, Sarrazin J, Faessel M, Latxague C, Boulenger de Hauteclocque A, Capon G, Bensadoun H, Robert G, Ferrière JM, Bos F, Bernhard J. Apport de l’impression 3D à la chirurgie rénale mini-invasive : pour l’information préopératoire spécifique – patient et pour l’enseignement de la lecture du scanner–(UroCCR study no 39–3DPRINT). Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
64
|
Vuong N, Capon G, Estrade V, Bensadoun H, Robert G, Ferriere J, Bernhard J. Amélioration dans le temps des résultats de la néphrectomie partielle robot-assistée (NPRA) : évaluation monocentrique de 370 procédures consécutives sur 6 années. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
65
|
Bergot C, Robert G, Guillaume A, Comat V, Lagabrielle S, Vuong N, Estrade V. Base pédagogique de la reconnaissance endoscopique des calculs, étude prospective monocentrique. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
66
|
Calën L, Gury-Coupier L, Michiels C, Vuong N, Capon G, Bensadoun H, Ferriere J, Robert G, Bernhard J. Chirurgie robot-assistée des cancers du rein avec thrombus cave : technique et faisabilité. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
67
|
Michiels C, Allenet C, De Hauteclocque A, Vuong N, Marquette T, Guillaume A, Comat V, Lagabrielle S, Gross-Goupil M, Capon G, Robert G, Bensadoun H, Ravaud A, Ferrière J, Bernhard J. Métastasectomie surrénalienne bilatérale robot-assistée pour Résection complète d’un cancer du rein métastatique. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
68
|
Gury L, Robert G. Curage de masses résiduelles de TGNS robot assistée. Intérêt de la voie rétrograde sous-mésocolique. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
69
|
Robert G, De La Taille A, Descazeaud A. Données épidémiologiques en rapport avec la prise en charge de l’HBP. Prog Urol 2018; 28:803-812. [DOI: 10.1016/j.purol.2018.08.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2018] [Accepted: 08/08/2018] [Indexed: 10/28/2022]
|
70
|
Marquette T, Klein C, De Graeve B, Mallet R, Houssin V, Rizk J, Comat V, Bernhard J, Capon G, Ferrière J, Robert G. Évaluation de la fonction érectile après énucléation prostatique au laser holmium. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
71
|
Michiels C, Jambon E, Latxague C, Hauteclocque ABD, Allenet C, Vuong NS, Maiga S, Capon G, Robert G, Bensadoun H, Grenier N, Ferrière JM, Bernhard J. Néphrectomie partielle robotique pour tumeur rénale assistée par modélisation 3D : série prospective de 100 cas et analyse comparative avec le registre national de néphrectomie partielle robot-assistée RoPaN (UroCCR study no 51). Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
72
|
Houssin V, Villers A, Robert G, Marquette T, Mallet R, Baumert H, Rizk J. Incidence de l’incontinence urinaire après holep : registre descriptif, prospectif, national, multicentrique. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
73
|
Robert G, de la Taille A, Descazeaud A. [Surgical treatment of BPO: Standard and innovations]. Prog Urol 2018; 28:856-867. [PMID: 30297185 DOI: 10.1016/j.purol.2018.07.287] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Accepted: 07/30/2018] [Indexed: 12/12/2022]
Abstract
INTRODUCTION AND OBJECTIVE Surgical management of benign prostatic hyperplasia has dramatically changed in the recent years towards higher proportion of endoscopic treatment and fewer perioperative complications. Nevertheless the question of urinary and sexual quality of life after surgical treatment remains partially unresolved with a high proportion of retrograde ejaculation after conventional surgical treatments. Therefore mini-invasive alternatives to conventional surgery have been proposed. The objective of this literature review was to provide an overview of the alternatives to monopolar TURP currently available in France. MATERIAL AND METHOD A non-systematic review of the scientific literature was conducted from the PubMed database to retrieve the most relevant scientific publications. A first research was cross-referenced with the results of literature reviews already published and enriched by the authors of this review. A synthesis is proposed for each alternative technique mentioning its level of clinical development, but also its potential advantages and disadvantages compared to conventional surgical techniques. RESULTS The quality of life of patients after surgical or interventional management has become the main priority of urologists since the risks of perioperative complication have been reduced by the use of laser or bipolar endoscopic techniques. Thanks to the development of minimally invasive alternatives that are better and better evaluated by randomized trials versus interventional simulation and conventional surgical treatment, more personalized care is possible. Patients' expectations and their individual risk factors can thus be placed at the center of the therapeutic decision and the preoperative information. CONCLUSION The surgical and interventional management of LUTS due to BPH has evolved to lower perioperative morbidity with the help of numerous technological developments. Mini-invasive alternatives to standard treatment have also been proposed in order to improve the quality of postoperative sexual life. These alternatives provide significant improvement in LUTS that remains lower than after conventional treatments. Somme of these alternative are also not fully supported by clinical trials, which should urge urologists to act with caution when proposing these alternatives in daily clinical practice.
Collapse
|
74
|
de la Taille A, Robert G, Descazeaud A. [Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery]. Prog Urol 2018; 28:813-820. [PMID: 30262261 DOI: 10.1016/j.purol.2018.08.013] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2018] [Revised: 08/16/2018] [Accepted: 08/27/2018] [Indexed: 12/22/2022]
Abstract
OBJECTIVE Our objective was to evaluate bladder outlet obstruction (BOO) consequences on the detrusor activity, to analyze the impact of medical and surgical treatments, and to study the reasons for recurrence of urinary symptoms after surgical treatment. METHOD A non-systematic review of the scientific literature was conducted from the PubMed database to retrieve the most relevant scientific publications between 2000 and July 2018 with the keywords: BPH, bladder obstruction, bladder instability, surgery, and reoperation. A first research was crossed with the results of the reviews of literature already published and was enriched by the contributions of the various authors. A synthesis has been proposed. RESULTS The consequences of bladder outlet obstruction (BOO) on the detrusor may be detrusor overactivity (DOA) or detrusor hypocontractility. DOA is found in about 50% of patients at the time of their surgery and its evolution is most often favorable after surgical treatment (resolved or reduced in 2/3 of cases). Bladder hypocontractility is responsible for acute or chronic urinary retention. It can be the cause for poor postoperative micturition recovery requiring self-catheterization which the patient must have been informed before surgical treatment. Surgery reduces urinary symptoms with a low but significant surgical revision rate (10 to 30% depending on the surgical technique). The less efficient technique with regard to surgical revision rates are prostatic radiofrequency or cervico-prostatic incision, followed by laser vaporization techniques, TURP and adenomectomy (surgical or endoscopic). Adenomectomy is the surgical technique that has the lowest recurrence rate. The identified risk factors for surgical revision are the surgeon's experience, the power of the laser (in case of photovaporization), the surgical technique employed, the length of operative time, the low or excessive volume of the prostate, the significant pre-operative post-void residual volume, and the slight decrease of postoperative PSA level. Prior to any surgical revision for recurrence of urinary symptoms, the assessment should include the review of previous surgical report, the evaluation of the resected prostatic volume and the residual prostatic volume, the IPSS score, the calendar of micturition, the urethrocystoscopy and the urodynamic assessment. CONCLUSION BOO can lead to bladder dysfunction such as DOA or detrusor hypocontractility. Resolution of BOO by a suitable surgical treatment allows, in the majority of the cases, to resolve bladder dysfunctioning. In case of failure, the assessment must be complete to define the causes and to find the most suitable solution.
Collapse
|
75
|
de la Taille A, Descazeaud A, Robert G. [How to prevent LUTS due to BPH development and progression]. Prog Urol 2018; 28:821-829. [PMID: 30262262 DOI: 10.1016/j.purol.2018.08.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2018] [Revised: 08/15/2018] [Accepted: 08/27/2018] [Indexed: 11/26/2022]
Abstract
OBJECTIVE Our objective was to define potential risk factors for lower urinary tract symptoms (LUTS) related with benign prostatic hyperplasia (BPH). METHOD A non-systematic review of the scientific literature was conducted from the PubMed database to extract the most relevant scientific publications between 2000 and July 2018 and cross them with the recommendations of the AFU and the EA by combining the keywords HBP with diet, diet, physical activity, spa treatments, tobacco, alcohol, cardiovascular risk factors, testosterone or inflammation. A synthesis has been proposed in order to identify the important elements to proscribe or modify in order to limit the development and progression of LUTS/BPH. RESULTS LUTS due to BPH are clearly associated with erectile dysfunction, cardiovascular diseases and metabolic syndrome. Some reversible risk factors have been identified such as low physical activity, overweight and hypercaloric nutrition. Interventions such as increased physical activity, weight-loss, and a diet including vegetables, tomatoes, carrots, vitamin E, lycopene, selenium, carotene, correction of the metabolic syndrome, stress reduction, and a suitable urinary behavior may impact progression of the disease. CONCLUSION Education of the patients on reversible risk factors for LUTS due to BPH is crucial and should be included in everyday practice. Physical activity and weight-loss are the most important factors to take into account. LEVEL OF EVIDENCE 5 consensus d'experts.
Collapse
|